🔎 Trials Near Me

Akèy › Limfòm folikilè › Oregon › Portland

Etid klinik pou Limfòm folikilè nan Portland, OR

9 etid pou Limfòm folikilè ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Ap rekriteFaz 3
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07215910

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Ap rekriteEtid obsèvasyon
  • OHSU Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06784167

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Ap rekriteFaz 1
  • Oregon Health & Science University (OHSU), Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07226843

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Ap rekriteFaz 2
  • Research Site, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06526793

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • Oregon Health Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • Oregon Health & Science University, Portland
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

Study of SGR-1505 in Mature B-Cell Neoplasms

Ap rekriteFaz 1
  • Oregon Health and Science University - Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Portland
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Ap rekriteFaz 1
  • Oregon Health & Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05780034

Etid Limfòm folikilè nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.